Pharmacist-led Intervention to Enhance Medication Adherence in Post-acute Coronary Syndrome Patients in Vietnam
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02787941|
Recruitment Status : Unknown
Verified May 2016 by Katja Taxis, University of Groningen.
Recruitment status was: Recruiting
First Posted : June 1, 2016
Last Update Posted : June 1, 2016
|Condition or disease||Intervention/treatment||Phase|
|Acute Coronary Syndrome Medication Adherence||Behavioral: Pharmacist-delivered multifaceted intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||140 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Pharmacist-delivered Multifaceted Intervention to Enhance Medication Adherence Among Post-acute Coronary Syndrome Patients in Vietnam: A Randomised Controlled Trial|
|Study Start Date :||November 2015|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||February 2017|
Experimental: Intervention group
The intervention group will receive the pharmacist-delivered multifaceted intervention with two counselling sessions in addition to usual care.
Behavioral: Pharmacist-delivered multifaceted intervention
First counselling: A pharmacist performs a 30-minute in-person counselling within 1 week before discharge including: (1) assessment and giving advice on basic knowledge of acute coronary syndrome: definition, risk factors, possible cardiac events, and prevention; (2) assessment of past experiences of using medications, encouragement and tailored advice; (3) providing support with pill organiser and drug information leaflet; (4) teaching back and correcting misunderstanding.
Second counselling: A pharmacist performs a 30-minute telephone counselling within 1 week after discharge including: (1) assessment of general and medication-related issues patients concerning; (2) encouragement and tailored advice; (3) teaching back and correcting misunderstanding.
No Intervention: Control group
The control group will receive usual care without the pharmacist-delivered multifaceted intervention.
- Proportion of patients adherent to medication at 1 month after discharge as assessed by the Morisky Medication Adherence Scale - 8 items [ Time Frame: 1 month ]
- Proportion of patients adherent to medication at 3 months after discharge as assessed by the Morisky Medication Adherence Scale - 8 items [ Time Frame: 3 months ]
- Proportion of patients readmitted to hospital of any cause at 3 months. [ Time Frame: 3 months ]
- Proportion of patients dying of any cause at 3 months. [ Time Frame: 3 months ]
- Change in quality of life from baseline assessed with EuroQol questionnaire EQ-5D-3L at 3 months. [ Time Frame: Baseline and 3 months ]
- Change in beliefs about medicines from baseline assessed with the Beliefs about Medicines Questionnaire (BMQ) at 3 months. [ Time Frame: Baseline and 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02787941
|Contact: Katja Taxis, PhD||0031 50 firstname.lastname@example.org|
|Contact: Thang Nguyen, MSc||84 email@example.com|
|Principal Investigator:||Katja Taxis, PhD||Unit PharmacoTherapy, -Epidemiology & -Economics, Faculty of Mathematics and Natural Sciences, University of Groningen, The Netherlands|